4//SEC Filing
Meyer Colin John 4
Accession 0001209191-23-016380
CIK 0001358762other
Filed
Mar 5, 7:00 PM ET
Accepted
Mar 6, 5:04 PM ET
Size
24.1 KB
Accession
0001209191-23-016380
Insider Transaction Report
Form 4
Meyer Colin John
See Remarks
Transactions
- Conversion
Class A common stock
2023-03-02+88,636→ 179,149 total - Sale
Class A common stock
2023-03-02$85.23/sh−22,752$1,939,153→ 156,397 total - Sale
Class A common stock
2023-03-02$86.49/sh−34,794$3,009,333→ 121,603 total - Sale
Class A common stock
2023-03-02$87.55/sh−19,099$1,672,117→ 102,504 total - Sale
Class A common stock
2023-03-02$88.50/sh−11,181$989,519→ 91,323 total - Sale
Class A common stock
2023-03-02$90.58/sh−810$73,370→ 90,513 total - Sale
Class A common stock
2023-03-03$87.35/sh−5,286$461,732→ 85,227 total - Exercise/Conversion
Employee Stock Option (right to buy)
2023-03-02−88,636→ 0 totalExercise: $11.00Exp: 2026-05-25→ Class B common stock (88,636 underlying) - Exercise/Conversion
Class B common stock
2023-03-02$11.00/sh+88,636$974,996→ 162,940 total→ Class A common stock (88,636 underlying) - Conversion
Class B common stock
2023-03-02−88,636→ 74,304 total→ Class A common stock (88,636 underlying)
Footnotes (9)
- [F1]The Class B common stock is convertible into Class A common stock on a one-for-one basis at the holder's election at any time. The conversion right of the Class B common stock has no expiration date.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions on one day at prices ranging from $85.00 to $85.99. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
- [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions on one day at prices ranging from $86.00 to $86.99. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
- [F4]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions on one day at prices ranging from $87.00 to $87.98. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
- [F5]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions on one day at prices ranging from $88.00 to $89.80. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
- [F6]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions on one day at prices ranging from $90.03 to $90.99. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
- [F7]The sale reported on this line represents shares sold by the reporting person to cover tax withholding obligations in connection with the vesting and settlement of restricted stock units.
- [F8]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions on one day at prices ranging from $87.35 to $87.36. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
- [F9]The options vested in sixteen equal quarterly installments beginning on August 25, 2016.
Documents
Issuer
REATA PHARMACEUTICALS INC
CIK 0001358762
Entity typeother
Related Parties
1- filerCIK 0001662392
Filing Metadata
- Form type
- 4
- Filed
- Mar 5, 7:00 PM ET
- Accepted
- Mar 6, 5:04 PM ET
- Size
- 24.1 KB